Corrigendum to "Comprehensive in-silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small molecular inhibitors for the treatment of Cholangiocarcinoma" [Comput. Biol. Med. 166 (2023) 107572]
1 Department of Biotechnology, Birla Institute of Technology and Science (BITS), Pilani Dubai Campus, Academic City, Dubai, 345055, United Arab Emirates; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
2 Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates; Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates.
3 Department of Biotechnology, Birla Institute of Technology and Science (BITS), Pilani Dubai Campus, Academic City, Dubai, 345055, United Arab Emirates.
4 Institute of Molecular Immunology and Experimental Oncology, Klinikum rechts der Isar, Technical University Munich, 81675, Germany. Electronic address: sainitin.donakonda@tum.de.